InsidersTradesSigma
Newbury Pharmaceuticals AB: management transactions · Finland · FIN-FSA
FI:newbury-pharmaceuticals-ab-c99156SE0015244884FI·FIN-FSAMcap 43M€Healthcare
Browse the full directors' dealings record of Newbury Pharmaceuticals AB, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Newbury Pharmaceuticals AB has logged 2 reports. Market capitalisation: €42.9m. The latest transaction was disclosed on 18 November 2025 — Purchase. Among the most active insiders: Alsakali Equity AB. Every trade is accessible without an account.
2
Insider Decl.
0
Thresholds
€12,328
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
1.41 €
Analyst consensus
Income statement
Revenue36.8 M€
Gross profit16.0 M€44% margin
Net income−15.4 M€-86.9% margin
Valuation
P/Book1.4x
Beta1.22
Balance sheet & cash
Market cap42.9 M€
Free Cash Flow−14.6 M€
Profitability & ownership
ROE-74.9%
ROA-18.4%
% insiders77.3%
% institutions5.2%
Last declaration on 18 November 2025
Declarations0 total
No declarations found
0 of 0 declarations